Reference
Institute for Clinical and Economic Review. Institute for Clinical and Economic Review Report on Voretigene Neparvovec Suggests Substantial Price Discount Needed to Meet Traditional Cost-Effectiveness Standards. Internet Document : 12 Jan 2018. Available from: URL: https://icer-review.org/announcements/voretigene-evidence-report/
Rights and permissions
About this article
Cite this article
ICER recommends price drop for voretigene neparvovec. PharmacoEcon Outcomes News 795, 2 (2018). https://doi.org/10.1007/s40274-018-4640-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-4640-9